Centre Consults Private Hospitals on Surgical Consumable Pricing

Key Financial Takeaways

  • The government is investigating wide gaps between procurement costs and maximum retail prices of surgical consumables.
  • A state government survey found markups of up to 2,841% on some surgical consumables and medical devices.
  • The Department of Pharmaceuticals is leading the consultations with hospital operators and state regulators.

💡 Why It Matters

The government's investigation and consultations aim to address concerns over high prices of surgical consumables and ensure fair billing practices in private hospitals. This move is significant as it could impact the cost of healthcare services for patients and the profitability of hospital operators.

Government Probes Hospital Billing Practices

The Indian government has initiated consultations with private hospitals regarding their billing practices and the pricing of surgical consumables. This move comes after state regulators flagged significant discrepancies between the procurement costs of these items and the maximum retail prices charged to patients.

Wide Price Gaps Reported

A survey conducted by a state government found that some surgical consumables and medical devices were being sold at markups of as high as 2,841% over their trade procurement prices. Regulators in Punjab, Rajasthan, and Tamil Nadu have also raised concerns about high margins on these items.

Products Under Scrutiny

The products being examined include IV sets, syringes, catheters, cannula extension lines, nebuliser oxygen masks, and filters. These items are not directly subject to ceiling prices under the Drugs (Prices Control) Order, 2013.

Hospital Representatives Cite Complexities

Hospital representatives told the Department of Pharmaceuticals that the difference between procurement prices and printed maximum retail prices (MRPs) should not be considered as the hospitals' realised margin. They pointed to complexities such as package-based insurance billing and costs associated with infection control, nursing, sterile storage, inventory, and wastage.

Next Steps

The Maharashtra government has announced a comprehensive inquiry and action against excessive pricing. The Department of Pharmaceuticals will continue its consultations with hospital operators and state regulators to address these concerns.

🏛️ Background & Context

The Indian government has been actively working to regulate the pharmaceutical and healthcare sectors. The consultations with private hospitals are part of a broader effort to ensure transparency and fairness in billing practices and pricing of essential medical devices.

👁️ What To Watch Next

The outcome of these consultations and the government's policy response will be crucial to watch. Potential developments include the implementation of trade‑margin caps or structured price monitoring for essential devices.

Source Attribution:
  • Mint